米非司酮\米索前列醇联合利凡诺终止14~24W妊娠的临床观察
第1页 |
参见附件。
摘要:目的 探索米非司酮、米索前列醇联合利凡诺在孕14~24w引产中的临床效果。方法 回顾性分析米非司酮、米索前列醇联合利凡诺选择性用于156例孕14~24w妊娠妇女在引产中的临床疗效及安全性,并与单用利凡诺引产结果进行比较。结果能明显缩短产程,减轻患者痛苦,增加引产的成功率,产时产后2h流血少,无软产道损伤。结论 米非司酮、米索前列醇联合利凡诺是一种安全、简便、有效的引产方法,在临床上有值得推广应用的价值。
关键词:米非司酮;米索前列醇;利凡诺;妊娠;引产效果
Clinical Observation of Mifepristone, Misoprostol and Rivanol 14~24W Pregnancy
HUANG Yue-ping
(Ningxiang County Family Planning Service Station,Changsha 410600,Hunan,China)
Abstract:ObjectiveTo explore the clinical effect of mifepristone, misoprostol combined with ethacridine in induction of labor in pregnant 14~24W. MethodsA retrospective analysis of mifepristone, misoprostol combined with ethacridine selectivity for clinical efficacy and safety of 156 cases of pregnancy 14~24W pregnant women in the induced labor, and compare the results with rivanol ......
您现在查看是摘要介绍页,详见PDF附件。